Relationship between mephenytoin oxidation polymorphism and phenytoin, methylphenytoin and phenobarbitone hydroxylation assessed in a phenotyped panel of healthy subjects.-Reference-Cited by-同舟云学术

Relationship between mephenytoin oxidation polymorphism and phenytoin, methylphenytoin and phenobarbitone hydroxylation assessed in a phenotyped panel of healthy subjects.

Published:1990-06 Issue:6 Volume:29 Page:665-671
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:British Journal of Clinical Pharmacology

Author:

Schellens JH,Wart JH,Breimer DD

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2125.1990.tb03687.x/fullpdf

Reference32 articles.

1. Importance of genetic factors in the regulation of diazepam metabolism: Relationship to S-mephenytoin, but not debrisoquine, hydroxylation phenotype;Bertilsson;Clin. Pharmac. Ther.,1989

2. Assessment and Prediction of In Vivo Oxidative Drug Metabolizing Activity

3. Impairment of phenytoin parahydroxylation as a cause of severe intoxication;Wolff;Ther. Drug. Monit.,1983

4. Plasma level monitoring of anticonvulsants;Eadie;Clin. Pharmacokin.,1976

5. The genetic polymorphism of sparteine metabolism;Eichelbaum;Xenobiotica,1986

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polymorphism of human cytochrome P450 enzymes and its clinical impact;Drug Metabolism Reviews;2009-05

2. Pharmacogenetics: Part II;Annals of Pharmacotherapy;2007-12

3. Pharmacogenetics, Drug-Metabolizing Enzymes, and Clinical Practice;Pharmacological Reviews;2006-09

4. Active-site characteristics of CYP2C19 and CYP2C9 probed with hydantoin and barbiturate inhibitors;Archives of Biochemistry and Biophysics;2004-09

5. Depression of phenytoin metabolic capacity by 5-fluorouracil and doxifluridine in rats;Journal of Pharmacy and Pharmacology;2003-01